A study of the effector cell responsible for immunity in mice to Francisella tularensis strain Schu by Peckinpaugh, Stephen D.
University of Montana 
ScholarWorks at University of Montana 
Graduate Student Theses, Dissertations, & 
Professional Papers Graduate School 
1975 
A study of the effector cell responsible for immunity in mice to 
Francisella tularensis strain Schu 
Stephen D. Peckinpaugh 
The University of Montana 
Follow this and additional works at: https://scholarworks.umt.edu/etd 
Let us know how access to this document benefits you. 
Recommended Citation 
Peckinpaugh, Stephen D., "A study of the effector cell responsible for immunity in mice to Francisella 
tularensis strain Schu" (1975). Graduate Student Theses, Dissertations, & Professional Papers. 6649. 
https://scholarworks.umt.edu/etd/6649 
This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of 
Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an 
authorized administrator of ScholarWorks at University of Montana. For more information, please contact 
scholarworks@mso.umt.edu. 
A STUDY OF THE EFFECTOR CELL RESPONSIBLE FOR 
IMMUNITY IN MICE TO FRANCISELLA TULARENSIS STRAIN SCHU
by
STEPHEN D. PECKINPAUGH 
B.A., Eastern Washington State College
Presented in partial fulfillment of the requirements for the
degree of
Master of Science
UNIVERSITY OF MONTANA
1975
Approved by:
c  ̂ ^ ^
Chairman, Board of Examiners
■ r  .r  ̂ r  _ _ _ _ _Dear^ Gr/rdu^te School
13. H7Ù 
D ate^ /
UMI Number: EP37450
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
UMI
Oi«»ertation F\jblj«htng
UMI EP37450
Published by ProQuest LLC (2013). Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code
ProQ^sf
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106 - 1346
\
ACKNOWLEDGEMENTS
I am indebted to my mentor, Dr* Carl L. Larson for 
his guidance and advice throughout the course of this 
study.
I would like to thank Drs. Walter E. Hill, Jon A. 
Rudbach, and Richard Ushijima for their assistance*
I would also like to thank the staff the Stella 
Duncan Memorial Institute for giving me much of their 
time and materials*
Above all, I would like to express my sincere ap­
preciation to my wife, Gere* Her love, encouragement, 
and unending patience, has been an inspiration to com­
plete this study*
This study was supported by a U* S* Public Health 
Service Research Grant, CA 12795.
ii
Peckinpaugh, Stephen D . ,
M.S», Fall Quarter, 1975 Microbiology
A Study of the Effector Cell Responsible for Immunity 
in Mice to Francisella Tularensis Strain Schu (67 pp.)
Director: Carl L. Larson '' ^ W-
Although mononuclear phagocytes have been postulated 
to be important in acquired immunity to tularemia, a mecha­
nism of resistance which involves these cells has not been 
clearly defined. The purpose of this study was to inves­
tigate the participation of macrophages as effector cells 
in the immune response to infection with Francisella tula­
rensis.
Mice were immunized with the live vaccine of tula­
rensis or with ether extracted antigens (EEA) of F̂ . tula­
rensis. Although comparable levels of specific arTtibody 
were induced by both vaccines, only inoculation with viable 
cells provided protection against challenges with highly 
virulent F̂ . tularensis strain Schu. The following lines 
of evidence indicated that this resistance involved acti­
vated macrophages with increased bacteriocidal capabili­
ties. 1. Treatment with Min-U-Sil, an agent which is 
cytotoxic for macrophages, rendered immune mice fully 
susceptible to challenges with low numbers of virulent 
tularemia bacilli. 2. Activated macrophages appeared in 
the peritoneal cavity of immune mice following an ip chal­
lenge with viable F̂ . tularensis strain Schu organisms.
3. Ether extracted antigen (EEA) provoked a response in 
tularemia-immune mice that was protective against chal­
lenges with unrelated Salmonella typhimurium. The devel­
opment and duration of this response correlated with the 
presence of activated macrophages in the peritoneal cavity.
Resistance in mice to JF. tularensis strain Schu fol­
lowing immunization with viable vaccine organisms was ac­
companied by the acquisition of delayed hypersensitivity 
to EEA. In addition, the elicitation of nonspecific 
resistance to Sm typhimurium with a single injection of 
EEA was associated with three manifestatlons of delayed 
hypersensitivity: a temporary depression of the delayed 
cutaneous response to EEA, the apparent loss of macro­
phages from the peritoneal cavity, and an increase in the 
percentage of activated peritoneal macrophages. Together, 
these data indicated that a single cellular mechanism may 
have provided the basis for both delayed hypersensitivity 
to cellular antigens and immunity to infection with homo­
logous or heterologous challenge organisms.
iii
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CHAPTER I 
INTRODUCTION
A role for mononuclear phagocytes in host resistance 
to pathogenic bacteria was initially postulated by Metchni- 
koff in the late nineteenth century. Since that time, the 
importance of the reticuloendothelial system in the preven­
tion of disease has been well documented (37-40, 69, 80). 
Against many infections, phagocytic cells together with 
humoral factors provide the defense mechanism vital for 
host survival.
Certain pathogenic organisms cause disease because 
they are allowed to multiply freely in the extracellular 
fluids. The pathogenicity of these obligate extracellular 
parasites have been related to the anti-phagocytic nature 
of their cell walls (13, 77, 80). Phagocytosis of these 
microorganisms is facilitated by the production of specific 
antibody in response to bacterial surface antigens (13, 78, 
80). Once ingested by macrophages, these bacteria are 
quickly killed. The immune state of an animal to these 
obligate extracellular parasites can be correlated with 
specific antibody titers, and resistance can be passively 
transferred to normal recipients with convalescent serum 
(80). In contrast, other pathogenic bacteria are readily 
engulfed by the phagocytic cells of the reticuloendothelial
1
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system but are able to resist intracellular degradation.
In this case, pathogenicity is related to the microorgan­
isms* ability to survive and to proliferate within host 
cells (69). Bacteria with this capability are collectively 
referred to as facultative intracellular parasites and in­
clude species of Mycobacterium. Listeria, Brucella. Sal­
monella . and Francisella.
The concept of acquired cellular immunity emerged 
when it was demonstrated that resistance to the facultative 
intracellular parasites was due to the increased bacteri­
cidal capabilities of the phagocytic cells of an infected 
animal. Work by Lurie (36) showed the macrophages from 
rabbits immune to infection with tubercle bacilli ingested 
acid-fast bacilli at a greater rate than normal macro­
phages and could suppress the intracellular growth of 
tubercle bacilli when transferred to the anterior chamber 
of the eye of a normal rabbit. A few years later, Suter 
(68) confirmed Lurie * s findings and demonstrated that mac­
rophages taken from guinea pigs infected with an attenu­
ated strain of Mycobac terium bovis (BCG) effectively 
limited the growth of virulent tubercle bacilli l_n vitro. 
More recently, Mackaness (37) demonstrated that macrophages 
capable of resisting intracellular growth of Listeria Mono­
cytogenes appeared in the peritoneal cavity of mice fol­
lowing infection with these organisms. The time of appear­
ance of the resistant macrophages coincided with the dis-
3
appearance of viable organisms from the spleen and liver* 
Since then, increased macrophage function has been shown 
to be important in the prevention of salmonellosis (7,
39), brucellosis (25, 38), and tularemia (51, 70). Al­
though there is little dispute that the effector cells 
responsible for acquired immunity to these facultative 
intracellular parasites are mononuclear phagocytes, the 
requirement for specific antibody has been debated. Many 
investigators (7, 25, 38, 39, 51) have suggested that ac­
quired cellular immunity is primarily due to a change in 
the intrinsic properties of the phagocytic cells, indepen­
dent of specific humoral factors. Other authors, however, 
have argued that specific antibody plays an important role 
in cellular resistance to the facultative intracellular 
parasites. Fong, et (19) reported that cultured mac­
rophages from BCG-immunized rabbits resist the necrotizing 
effect of virulent tubercle bacilli only in the presence 
of serum from immune animals. Jenkin and Benacerraf (26) 
found the amount of phagocytosis iji vi tro and the rate of 
intracellular killing of virulent Salmonella typhimurium 
were enhanced if the organisms were treated first with 
immune serum. Further work by Jenkin and Rowley (27) 
showed that resistance to typhimurium can be passively 
transferred with serum if sufficient amounts are used. The 
protective antibodies effective in salmonellosis were con­
tained in the IgM fraction of serum, and were found to be
4
cytophilie for macrophages (58).
One of the most notable features of acquired cellular 
immunity is that the mechanism of resistance induced by 
infection with the facultative intracellular parasites 
is effective against antigenically (40) and taxonomi- 
cally (60) unrelated organisms. Mice immunized with BCG 
have been shown to resist infection with Listeria (8), 
Burcella (67), or Salmonella (64). Animals infected with 
Listeria are, for a period of time, refractory to infec­
tion with Salmonella and vice versa (7). This lack of 
specificity in immunity to the facultative intracellular 
parasites has been shown vitro experiments to be 
dependent on mononuclear phagocytes with increased micro­
bicidal capabilities that are not directed exclusively 
against the original infecting organism (22, 60). In 
addition to these enhanced bactericidal capabilities, 
macrophages from mice immunized with BCG (8) or Listeria 
(38) have been shown to differ morphologically from nor­
mal macrophages. They appear larger than normal, contain 
greater than normal numbers of cytoplasmic organelles, 
attach more readily to glass, and spread more extensively 
(8, 38). It has been proposed that the morphology and 
behavior of these "activated macrophages" vitro faith­
fully reflect their microbicidal activity iji vivo. Mac­
rophages with similar features can also be found in mice
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inoculated 48 hours earlier with endotoxins of gram-nega­
tive bacteria (81), which also stimulate nonspecific 
immunity (65).
Explanations of the nature of the anti-microbial 
form of acquired cellular immunity have implied that 
there is a causal relationship between the state of de­
layed hypersensitivity and resistance to the facultative 
intracellular parasites. Mackaness (37) reported that 
following infection with Listeria monocytogenes , the 
acquisition of delayed hypersensitivity coincided with a 
sharp decrease in the number of viable bacteria within in­
fected tissues. A similar relationship between the devel­
opment of delayed hypersensitivity to cellular antigens 
and the onset of resistance occurs in mice infected with 
Brucella (38), Salmonella (11), or Francisella (10). The 
position that both delayed hypersensitivity and acquired 
cellular resistance have a similar or closely related 
mechanism has been further supported by the failure of 
killed vaccines of the above organisms to induce either 
delayed hypersensitivity or resistance (10, 11, 38). In 
addition, delayed hypersensitivity and acquired cellular 
immunity can be transferred concurrently to normal animals 
with lymphoid cells (41), and both immunologic phenomenon 
are suppressed by treatment with anti-lymphocyte serum 
(42). As tempting as it is to equate the mechanisms of 
delayed hypersensitivity and cellular immunity, one must
6
remember that delayed hypersensitivity is a cutaneous 
reaction involving the accumulation of cells at a skin 
test site, whereas anti-microbial cellular immunity in­
volves the intracellular inactivation of virulent bac­
teria. Also, resistance to the facultative intracellular 
parasites has been demonstrated in the absence of delayed- 
type hypersensitivity (3, 23, 57, 82).
Although the ultimate effector cells in anti-micro- 
bial immunity have been shown to be activated macrophages 
capable of destroying virulent organisms, the mechanism of 
resistance is thought to involve at least one other type 
of cell. Mackaness (41) showed that immunity to L. mono­
cytogenes could be transferred from mice that had recovered 
from Listeria infection to nonimmune mice with viable spleen 
cells. Spleen cells from BCG-vaccinated mice, however, did 
not confer immunity to Listeria in nonimmune recipients 
unless the recipient mice were given a small dose of BCG 
following the transfer of spleen cells. This provided 
evidence that a population of antigen-reactive lymphoid 
cells is required for the expression of cellular immunity, 
and that a specific antigen-lymphocyte interaction results 
in the stimulation of activated macrophages. The immuno­
suppressive effect of anti-lymphocyte globulin on immunity 
to L. monocytogenes (33), M. tuberculosis (20), and F. 
tularensis (9), has further implicated thymus-dependent 
lymphoid cells in the development of acquired cellular
7
immunity. In rats resistant to L. monocytogenes: , the 
antigen-reactive lymphoid cells important in cellular 
resistance have been shown to be rapidly labeled, short­
lived, non-recirculating lymphocytes (31, 43). These 
"committed" lymphocytes appeared in the thoracic duct 
lymph following an injection of live attenuated organisms, 
and conferred resistance to infection with L* monocyto­
genes upon normal recipients.
The nature of the contribution made by lymphoid 
cells in the expression of anti-microbial immunity is 
thought to involve soluble substances, other than immuno­
globulins, that are secreted by committed lymphocytes 
following specific antigenic stimulation (7, 41). Re­
searchers interested in developing vitro models of 
cellular immunity have characterized a wide range of 
lymphoid products which have effects on macrophages in 
vitro (53). The lymphokine of greatest interest has been 
migration inhibition factor (MIF), a nondialysable glyco­
protein with a molecular weight being between 60,000 and 
75,000, which inhibits the migration of macrophages (14, 
21). Lymphocytes cultured with antigen in vitro have 
also been shown to release substances that are chemotac- 
tic for macrophages (79), cause aggregation of macro­
phages in suspension (34), inhibit macrophage spreading 
on glass (18), and promote phagocytosis (5). The biolo-
8
gical activities of these lymphocyte products on macro­
phages iri vitro have been used to explain the events 
that occur during a delayed-type response in vivo (53), 
however their importance in acquired cellular immunity 
has yet to be proven. Simon and Sheagren (66) have 
reported that supernatant fluids from suspensions of 
antigen-stimulated lymphocytes inhibited the migration 
of macrophages without enhancing the ability of macro­
phages to kill L. monocytogenes. Patterson and Youmans 
(52) demonstrated that if lymphocytes from tuberculin- 
sensitive mice were incubated with tubercle antigens, 
these cells produced a soluble factor that suppressed 
the multiplication of tubercle bacilli in normal ihacro- 
phages. Further studies by Klun e_t aĵ . (30) have indi­
cated that the mycobacterial growth-inhibitory factor 
was different than migration inhibitory factor. Regard­
less of whether one or several lymphokines are responsible 
for resistance to the facultative intracellular parasites, 
an immune mechanism which involves the elaboration of 
soluble mediators by antigen-stimulated lymphoid cells 
is consistent with the concept of acquired anti-bacterial 
immunity.
The immune response to JF. tularensis has been studied 
in order to further elucidate the mechanism(s) responsible 
for resistance to bacteria that invade and proliferate
9
within cells of the reticuloendothelial system. Tulare­
mia is a good disease to study because the course of an 
experimental infection is rapid and uniformly fatal in 
mice, and can be initiated by small numbers of organisms 
(10). Also, £. tularensis organisms can be easily iso­
lated and maintained in pure culture, and prior contact 
of laboratory animals with these organisms is doubtful.
To date, the only effective means of protecting mice 
against the fully virulent strains of tularensis has
been to immunize them with live vaccine. Russian and 
Turkish investigators (cf. 74) were the first to report 
that live avirulent tularemia organisms were superior to 
killed preparations for immunization of mice and guinea 
pigs. Eigelsbach and Downs (16) have shown that two mor­
phologically distinct colony types, a gray varient (GV) 
and a blue varient (BV) are present in cultures of live 
tularemia vaccine. tularensis organisms of the latter
colony type were more virulent and provided better pro­
tection in the mouse and guinea pig. Although killed 
vaccines have proved immunogenic for the white rat (32), 
antigens prepared from F. tularensis have failed to pro­
tect the mouse and guinea pig challenged with strains of 
high virulence (6). Some protection, however, is afforded 
the mouse with killed vaccines when strains of low or mod­
erate virulence are given as the challenge organism.
The factors involved in resistance to tularemia
10
appear similar to those important in immunity to other 
facultative intracellular parasites. Resistance can be 
transferred from immune donors to normal recipients with 
viable cells, but not with serum (1). Killed vaccines 
are ineffective inducers of resistance (6, 9), and the 
onset of immunity to tularemia coincides with the devel­
opment of delayed hypersensitivity (10). Unlike immunity 
to other facultative intracellular parasites, however, 
resistance to tularemia has been shown to be specific 
(10). Effective stimulators of nonspecific resistance, 
like BCG, do not protect against virulent tularemia 
organisms, and immunization with avirulent tularemia 
organisms is effective only against the homologous 
challenge.
Statement of problem
The purpose of this research was to identify more 
clearly the effector cell that is important in resis­
tance to murine tularemia. Four lines of investigation 
were followed: (1) the effect of silica on immunity to
£,• tularensis strain Schu, (2) the relationship of the 
delayed hypersensitive state to resistance, (3) non­
specific aspects of immunity to F̂ . tularensis ; and (4) in 
vi tro observations of the host cellular response to spe­
cific challenge.
CHAPTER II 
MATERIALS AND METHODS
Animals
Rocky Mountain Laboratory (RML) outbred Swiss mice 
between 6-12 weeks of age were used throughout this study.
All groups of mice within an experiment were matched for 
age and sex.
Organisms
The live vaccine strain (LVS) Francisella tularensis 
RV15R and the highly virulent F. tularensis strain Schu 
were kindly supplied by Dr. J. Frederick Bell, Rocky Moun­
tain Laboratory, Hamilton, Montana. The LD^^ of LVS for 
6 7mice was 10 - 10 colony forming units (CFU) and of the
LD^g Schu was 1-10 CFU for mice or guinea pigs. The organ­
isms were cultured on chocolate agar slants made with glucose- 
cystine heart agar (Difco) supplemented with 5 percent fresh 
rabbit blood. Both strains were reisolated from experiment­
ally infected mice periodically to insure that the stock 
cultures did not decrease in virulence by repeated passage 
on artificial media.
The highly virulent Salmonella typhimurium, 5906, with 
1 2an LDgQ of 10 - 10 CFU for mice infected intraperitoneally
was obtained from Dr. Kelsey Milner, Rocky Mountain Laboratory,
11
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Hamilton. This organism was maintained on Trypticase- 
Soy agar (TSA), Difco, Slants, incubated at 4^C. Reiso­
lation of Salmonella organisms from experimentally in­
fected mice was done periodically to select for subse­
quent challenge organisms of high virulence.
Immunizing or challenge organisms were taken from 24 
hour plate cultures. After the bacterial cells were 
washed once in sterile physiological saline (SS), the 
bacteria were resuspended in SS, and the suspensions 
were adjusted to a turbidity reading of 100 (Klett-100) 
on the Klett Summerson photoelectric colorimeter fitted 
with a no. 42 blue filter. Serial tenfold dilutions 
were made, and 0.1 ml was plated on maintenance media 
to determine the concentration of colony forming units
(CFU) for each dilution. Klett-100 suspensions of F̂ .
8 9tularensis routinely contained 10 - 10 CFU per ml,
whereas Klett-100 suspensions of typhimurium cells 
contained 10^ - 10^ CFU per ml.
Antigens
Ether extracted antigen (EEA) was prepared from F. 
tularensis LVS using the method of Larson (32). Briefly, 
heavy suspensions of LVS cells made in sterile physio­
logical saline from 24 hour broth cultures were mixed 
with two volumes of cold ether. After 24 hours at room 
temperature, the ether phase was drawn off, and the saline
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phase was placed in a 80^C water bath in order to evapor­
ate any residual ether. The remaining suspension, now 
designated EEA, was adjusted to a Klett-100 turbidity 
and checked for sterility by spreading 0.1 ml on choco­
late agar. The EEA was stored in sealed serum bottles 
at until used. A dose of 0.2 ml of a Klett-100
suspension of EEA was used as a standard immunizing dose. 
Crude ribosomes from LVS cells were isolated by the pro­
cedure described by Baker ejb c^. (4). A buffered wash 
solution [O.OI M MgCl^, 0.01 M Tris-HCl (pH 7.4) 0.5 M 
NH^Cl] was used as a diluent throughout. The LVS cells, 
harvested from a 24 hour broth culture, were disrupted 
by a Sorvall-Ribi cell fract’ionator at a pressure of
30,000 psi. After the standard sequence of separatory 
centrifugations, the final solution of crude ribosomes 
was assayed for purity by sedimentation centrifugation. 
The concentration of the crude ribosomes was determined 
by measuring the optical density at 260 nm.
Francisella novicida cell walls, F. novicida proto­
plasm and BCG cell walls were obtained from the Stella 
Duncan Memorial Institute. All of the above antigens 
were used in a dose of 300 ugs (dry weight).
Commercially obtained Purified Protein Derivative 
(PPD) prepared from Mycobac terium tuberculosis was in­
jected in a dose of 35 pgs.
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Protection Tests
Resistance to 2* tularensis was quantified in groups 
of experimental and control mice injected with 0.2 ml of 
serial tenfold dilutions of the challenge organism. Both 
the subcutaneous and the intraperitoneal routes of inocula­
tion were used. Deaths were recorded for 14 days, and 
the LDgQ and the mean time to death (MTD) was calculated 
for each group by the Reed-Muench method (57).
Experiments to measure the resistance of mice to _S. 
typhimurium were performed in a similar manner as de­
scribed above for the F. tularensis challenge. However, 
injections were always made intraperitoneally, and the 
mortality was followed for 30 days post-infection.
Serologic Tests
Pooled sera from control mice and mice inoculated 
14 days previously with immunizing doses of EEA or LVS 
organisms were assayed for specific bacterial agglutinins 
by the standard tube bacterial agglutination test. Serial 
twofold dilutions (0.5 ml) were made for each serum with 
saline, and equal (0.5 ml) volumes of a Klett-200 sus-
9pension of LVS cells (approximately 10 cells) were added 
to each tube. The bacterial agglutination titer was de­
termined as the reciprocal of the highest dilution of 
serum causing positive agglutination in duplicate tubes 
after incubation for 1 hour at 37^C followed by 4 hours at 
4°C.
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Specific and cross-reacting bacterial agglutination 
titers were also determined for mice immunized with viable 
LVS organisms or heat killed _S. typhimurium cells. For 
this test, however, suspensions of formalin killed LVS 
and typhimurium cells were used as agglutinogens.
Footpad Reactivity to Injected EEA
Immediate hypersensitivity (8 hour reactivity) and 
delayed hypersensitivity (reactivity after 24 hours) to 
subdermal injections of EEA were determined in individual 
mice. Routinely, 0.03 ml of a Klett-100 suspension of 
EEA was injected beneath the skin of the left rear foot­
pad, and an equal volume of SS was injected into the right 
rear footpad as a control. The reaction provoked by the 
injected EEA was determined after 8 hours and after 24 
hours by measuring the thickness of both rear footpads 
with a dial gauge caliper (Schnelltaster, Kroplin). The 
difference between the two measurements for each animal 
indicated the intensity of the reaction. Significance 
in the differences of the delayed reactions in each group 
was calculated by the Student's-t test.
Peritoneal Clearance of typhimurium
Small groups of mice were inoculated intravenously 
with 1.7 X 10^ CFU JP. tularensis LVS or with 0.2 of a Klett- 
100 suspension of EEA, and were boosted 14 days later with 
an ip injection of 0.2 ml of a Klett-100 suspension
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of EEA. The ability of the treated and control mice to 
eliminate _S. typhimurium cells from the peritoneal cavity, 
24 hours after the secondary ip injection of EEA, was 
determined•
Five mice from the experimental and control groups 
were injected with approximately 10^ viable typhimurium 
cells suspended in 0.2 ml of sterile saline. Thirty min­
utes later, the mice were killed by cervical dislocation, 
and the abdominal skin was reflected back. Four ml of 
cold saline were injected into the peritoneal cavity of 
each mouse, and the abdomen was gently kneaded to insure 
a homogeneous peritoneal exudate. Two ml of fluid were 
then withdrawn from the peritoneal cavity using a 5.0 ml 
syringe fitted with an 18 gauge needle and were mixed with
3.0 ml of saline. The cell suspension was centrifuged at 
100 X g for 5 minutes to sedimentate the peritoneal cells. 
The viable typhimurium remaining in the supernate were 
enumerated by plating 0.1 ml of serial tenfold dilutions 
in triplicate on nutrient agar and counting the colonies 
after incubation at 37^C for 24 hours. The colony counts 
were adjusted for dilution and were recorded as the total 
number of viable organisms recovered from the peritoneal 
fluid. The sedimented peritoneal exudate cells from the 
above procedure were resuspended in 5.0 ml of sterile 
distilled water and allowed to stand for 5 minutes. It 
had been previously determined that when mouse peritoneal
17
cells were suspended in distilled water, greater than 80% 
of the cells lysed within 5 minutes. The viable typhi- 
murium that were present in the peritoneal cell lysate 
were enumerated as before, and the colony forming units 
were recorded as the total number of viable organisms 
recovered from the peritoneal exudate cells.
In Vitro Macrophage Activation Assay
The effect of an intraperitoneal injection of 0.2 ml 
of a Klett-100 suspension of EEA upon peritoneal cells of 
mice immunized previously with standard doses of EEA or 
LVS organisms was determined.
Five mice from the experimental and control groups 
were killed by cervical dislocation at times after the 
secondary injection of EEA. The peritoneal cells were 
collected by injecting 3.0 ml of cold Hank's balanced 
salt solution (HESS) into the peritoneal cavity. After 
kneading the abdomen 20 times, 1.0 ml of the peritoneal 
fluid was recovered using a 1.0 ml disposable syringe 
fitted with an IB gauge needle. All bloody exudates were 
discarded. One-half of the peritoneal exudate was kept 
in a silicon-coated tube, and used to determine white cell 
number and differential count. The remaining 0.5 ml of 
exudate was diluted 1x10 with Eagle's minimum essential 
medium (MEM) containing 10% fetal calf serum. This rou­
tinely yielded a cell suspension of approximately
18
4 — 9 X 10^ peritoneal cells per ml. Four-tenths ml of 
this suspension was dispensed into one well of an 8- 
chambered slide. When all 8 chambers were filled with 
the peritoneal exudates from individual mice, the slide 
was incubated at 37^C. After 30 minutes, the plastic 
walls were removed and all nonadherent cells were re­
moved by washing 3 times with 5 ml volumes of HBSS flow­
ing from a pipet. The slides were fixed for 10 sec. in 
absolute methanol, stained with Harris Hematoxylin (Fis­
cher Scientific Co., Pittsburgh, Pa.), and counterstainéd 
with a 0.5% solution of fast green in 95% ethanol. The 
slides were examined microscopically and a total of 200 
macrophages counted. The number of macrophages with ex­
tensive cytoplasmic spreading, nuclear enlargement, and 
cytoplasmic granulation was used to determine the percent 
of macrophage activation.
CHAPTER III
RESULTS
Effects of immunization with viable F . 
tularensis strain LVS, or with non- 
viable ether extracted antigen (EEA)
Although comparisons of viable and nonviable vaccines
for the prevention of tularemia have been made elsewhere
(10, 16), initial experiments were performed to evaluate
the vaccines prepared for this study. Groups of 50 mice
3were immunized with 6.8 x 10 viable tularensis strain 
LVS, or with 0.2 ml of a Klett-100 suspension of EEA. 
Fourteen days later, groups of the experimental and control 
mice were challenged with serial tenfold dilutions of 
tularensis strain Schu. The remaining normal, EEA, and 
LVS-immunized mice were not challenged, but were tested at 
the same time for delayed hypersensitivity of EEA, and for 
the presence of specific circulating antibody.
Resistance to Schu Immunization with live vaccine pro­
vided mice (Table I) with 4.9 logs of protection, whereas 
mice receiving EEA remained susceptible to infection with 
as few as 20 Schu organisms. Although the EEA-immunized 
mice succumbed to infection with Schu organisms, they sur­
vived longer than the normal controls.
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Table I. Resistance to F̂ . tularensis strain Schu in mice 
immunized with EEA or LVS.
Challenge dose 
of Schu 
(CFU)
Results obtained 
Control 
d/t® MTD^
from mice 
EEA^ 
d/t MTD
treated with 
LVS^ 
d/t MTD
10®*^ 6/6 4.3 6/6 6.1 6/6 8.5
10^*^ 6/6 3.8 6/6 6.1 4/6 7.3
10^-3 6/6 5.0 6/6 7.1 2/6 -
10^*^ 6/6 5.3 6/6 8.0 0/6 -
10^*^ 6/6 5.3 6/6 8.1 1/6 -
10^*^ 6/6 7.7 4/6 8.0 0/6 -
20 CFU 20 CFU 10^' 9̂ CFU
^ Death/total mice challenged after 14 days.
^ Mean time to death in days
^ Inoculated with 0.2 ml Klett-100 EEA 14 days (iv), and 
7 days (ip) prior to challenge.
Immunized with 6.8 x 10 CFU LVS (iv), 14 days prior 
to challenge.
Antibody response The results of the bacterial ag­
glutination assay are reported in Table II. Detectable 
levels of specific circulating antibody were found in the 
serum from mice immunized with either LVS or EEA.
Footpad reactivity Table II shows that immediate 
(8-hour) hypersensitivity to injected EEA was found in
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mice immunized with either EEA or LVS. Delayed (24-hour) 
hypersensitivity to EEA were only observed in those mice 
inoculated with viable LVS organisms.
Table II. Delayed hypersensitivity to EEA and specific 
bacterial agglutination titers in mice immun­
ized with EEA or LVS.
Immunizing
antigen
Increase in 
thickness
footpad 
(mm )
Serum bacterial 
agglutination
8 Hr 24 Hr Titer*^
Control 0.04 - 0.05 0.01 - 0.03 < 5
EEA^ 0.31 i 0.13 0.08 i 0.08 80
LVS^ 0.27 i 0.12 0.53 - 0.15 40
^ Mean - standard deviation in groups of 10 mice.
^ Reciprocal of the highest dilution of serum showing 
positive bacterial agglutination.
^ Immunized with 0.2 ml Klett-100 EEA, 14 days (iv), 
and 7 days (ip) previously.
^ Immunized with 6.8 x 10^ CFU LVS i v . , 14 days pre­
viously.
Effect of si 1ica on resistance to Schu
Experiments by Allen (1) and Thorpe and Marcus (73) 
have shown that immunologically active cells and not cir­
culating antibody are important in acquired resistance to 
F̂ . tularensis. The iji vitro studies by Nutter and Myrvik 
(51) have suggested further that the effector cell ulti-
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responsible for the destruction of tularemia bac­
illi is the macrophage.
The requirement for the participation of macrophages 
in resistance to tularemia was investigated in this study 
Immune mice were treated with silica and challenged with 
virulent Schu organisms. Silica has been shown to be 
cytotoxic to macrophages ijn vivo (2), and ^  vitro (29). 
Normal mice, and mice immunized 14 days previously with 
3.5 X 10 viable LVS organisms, were injected ip with 
50 mg of silica (dry weight) suspended in sterile sal­
ine. Four hours later, groups of the experimental and 
control mice were challenged with serial tenfold dilu­
tions of Schu. Table III shows that the protection pro­
vided by primary immunization with LVS organisms was 
completely abrogated by the injection of silica. With 
a decreased number of macrophages, the LVS-immunized 
mice became susceptible to as few as 30 Schu organisms.
Resistance to Salmonella typhimurium 
in tularemia-immune mice
Acquired immunity to many of the faculative intra­
cellular parasites has been shown to involve a cellular 
component that is protective against unrelated bacteria 
(37, 38). Mackaness and Blanden (40) suggested that the 
degree of this nonspecific immunity was dependent on the 
presence of specific antigen within host tissues.
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Table III. The effect of 
ehsis strain 
viously with :
silica on immunity to 
Schu in mice immunized 
LVS.
F. tular- 
pre-
Results obtained from mice treated with
Normal LVS-immunized^
Challenge dose 
of Schu 
(CFU)
Control
d/t^
Silica^
d/t
Control
d/t
Silica
d/t
10^*^ 6/6 5/6 6/6 6/6
6/6 6/6 0/6 6/6
10^*^ 6/6 not done 1/6 5/6
10^*^ 6/6 6/6 0/6 6/6
10^*^ 6/6 6/6 0/6 4/6
"'*'50 30 CFU 30 CFU lo'^’^CFU 30 CFU
® Deaths/total mice challenged after 14 days.
^ Injected 
lenge.
ip with 50 mg silica, 4 hours prior to chal-
Immunized i V with 3.5 X: 10^ CFU LVS , 14 days prior to
challenge.
A series of experiments were performed to determine 
if nonspecific immunity to typhimurium could be ewoked 
in LVS-immunized mice with an injection of specific cel­
lular antigen (EEA). Previously, it was shown that immun­
ization with LVS alone did not enhance resistance to the 
unrelated organism (10).
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1. Resistance in LVS-immunized mice to Salmonella 
typhimurium. following ip injection of EEA*
Experiment I * Normal mice and mice inoculated with
32 X 10 viable organisms were given an ip injection of 
0.2 ml of a Klett-100 suspension of EEA. At times fol­
lowing the injection of antigen, groups of the experi­
mental and control mice were challenged ip with 6 x 10^ 
virulent typhimurium organisms. Table IV shows that 
the EEA was effective in stimulating resistance to the 
Salmonella in the LVS-immunized mice but only if given 
24 hours prior to challenge. LVS or EEA alone had no 
effect on the nonspecific resistance to Salmonella.
Experiment 2 . Groups of normal mice and mice inoculated
314 days previously with 3 x 10 viable LVS organisms were 
injected ip with 0.2 ml of a Klett-100 suspension of EEA. 
Twenty-four hours later, the groups of experimental and 
control mice were challenged ip with serial tenfold dilu­
tions of Ŝ . typhimurium. The results in Table V show that 
the combination of primary immunization with LVS and sec­
ondary treatment with EEA increased the LD^q of the Sal-
3monella challenge by more than 4 x 1 0  challenge organisms 
Mice receiving LVS or EEA alone were not protected.
2. Effects of ip, iv, or sc injections of EEA on non­
specific resistance in LVS-immunized mice.
This experiment was performed to determine if a
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Table IV. Resistance to typhimurium in mice immunized 
previously with LVS at times after an ip injec­
tion of specific antigen (EEA).
Group 1̂
Treatment 
LVS® 2° EEA^
Time prior to 
challenge (hr)
Mortality
d/t^
I - - - 8/8
II - + 0 7/8
III - + 24 7/8
IV - + 72 8/8
V - + 120 8/8
VI + — - 7/8
VII + + 0 7/8
VIII + + 24 1/8
IX + + 72 7/8
X + + 120 8/8
^ Immunized iv with 2 X 10^ CFU LVS, 14 days previously.
^ Injected ip with 
to challenge with
0.2 ml Klett- 
6 X 10 CFU
-100 EEA, at time 
S. typhimurium.
prior
^ Deaths/total mice challenged after 30 days.
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Table V, Resistance in LVS-immunized mice to infection
with nonspecific (^. typhimurium) organisms,
24 hours after an ip injection of EEA.
Mortality
Challenge dose 
S. typhimurium
f c F Ü T ----
Normal 1 
d/t^
^formal + EEA 
d/t
Immune^
d/t
Immune + EEA 
d/t
10^*^ 6/6 6/6 6/6 5/6
10^*® 6/6 6/6 6/6 6/6
10^*^ 5/5 5/5 6/6 2/6
10^*^ 6/6 5/6 6/6 1/6
10^*^ 4/6 4/6 4/6 0/6
^^50 80 CFU 80 CFU 80 CFU CFU
^ Immunized iv with 3 x 10^ CFU LVS, 14 days previously. 
^ Deaths/total mice challenged after 30 days.
secondary injection of EEA would stimulate nonspecific 
resistance to Salmonella if administered by iv or sc in­
oculation. Groups of normal mice and mice immunized 14 
days previously with LVS were given ip, iv, or sc injec­
tions of 0.2 ml of a Klett-100 suspension of EEA and were 
challenged 24 hours later with lethal doses of _S. typhi­
murium. The results in Table VI show that the EEA was 
effective in stimulating resistance to Salmonella only if 
injected by the route of challenge. Alternate routes of
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injection produced no significant increase in nonspecific 
resistance.
Table VI. Resistance to an ip infection of typhimur­
ium in normal mice and in mice immunized with 
tfVS, 24 hours after boosting with EEA by iv, 
sc, or ip injection.
Group
Treatment 
l^LVS^ 2^EEA^
Route of 
injection
Mortality
d/t^
I - - - 8/8
II - + iv 8/8
III - + sc 8/8
IV - + ip 8/8
V + - - 8/8
VI + + iv 7/8
VII + + sc 8/8
yiii + + ip 1/8
^ Immunized iv with 2.3 x 10^ CFU LVS.
^ Injected with 0.2 ml Klett-100 EEA by route given. 
^ Deaths/total mice challenged after 30 days.
3. Resistance to Salmonella in EEA-immunized mice 
following a secondary injection of EEA.
This experiment was performed to determine the re­
quirement of viable organisms (LVS) for the induction of 
immune mechanisms that can be activated by specific antigen 
(EEA) against a nonspecific challenge. Normal mice and
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mice immunized previously with a 1.7 x 10^ viable LVS 
organisms or with 0.2 ml of a Klett-100 suspension of 
EEA were boosted ip with EEA 24 hours prior to challenge. 
The results in Table VII show that resistance to non­
specific Ŝ m typhimurium occurred only in those mice that 
had received both the primary LVS and the secondary EEA 
injections. The secondary injections of EEA into EEA- 
immunized mice did not increase their resistance to the 
Salmonella challenge above normal levels.
Table VII. Resistance to 5.* typhimurium in normal mice, 
EEA-immunized mice, or LVS-immunized mice,
24 hours after an ip injection with 0.2 ml 
of a Klett-100 suspension of EEA.
Treatment Mortali ty
Group 1°LVS® l^EEA^ 2®EEA d/t®
I - - - 13/15
II - - + 16/17
III - + - 14/15
IV - + + 16/18
V + - - 17/19
VI + - + 2/15
^ Immunized 
challenge.
iv with 1.7 X 10^ CFU LVS, 14 days prior to
^  Immunized iv with 0.2 ml of a Klett-100 suspension of
EEA, 14 days prior to challenge.
^ Deaths/total mice challenged with 750 CFU typhi­
murium after 30 days.
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4. Role of humoral factors in nonspecific resistance to 
Salmonella in LVS immunized mice.
The possibility that the nonspecific resistance to 
Salmonella was due to the presence of cross-reacting 
antibodies was investigated. Serum from mice inoculated 
previously with LVS was checked for anti-Salmonella agglu­
tinins. Mice immunized with 1.7 x 10^ viable LVS organ­
isms were boosted ip with 0.2 ml of a Klett-100 suspension 
of EEA 3 days prior to serum collection. Table VIII shows 
that the bacterial agglutination test failed to demon­
strate the presence of anti-Salmonella antibody in the ; 
serum from mice immunized with LVS. Positive bacterial 
agglutination titers were found only in the specific 
control serums.
The effect of an ip injection of EEA on the rate of elimi­
nation of viable Salmonella organisms from the peritoneal 
cavities of LVS-immunized mice.
The possibility that the nonspecific resistance to 
typhimurium. elicited in tularemia-immune mice by an 
intraperitoneal injection of specific antigen, was due to 
an accelerated rate of peritoneal clearance was investi­
gated. Normal mice and mice inoculated 14 days previously
3with 1.7 X 10 viable LVS organisms were injected ip with
0.2 ml of a standard suspension of EEA. Twenty-four hours 
later, all mice were infected ip with approximately 3.5 x 
10^ viable Salmonella cells. Thirty minutes after the
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Table VIII. Bacterial agglutination titers in mice
immunized previously with tularensis 
strain LVS, or heat killed S. typhilnurTum.
Serum from mice 
immunized with
Titer 
F. tularensis S. typhimurium
Control < 5 <5
F. tularensis^ 40 <5
S. typhimurium^ < 5 160
^ Immunized 18 days previously with 1.7 x 10 CFU LVS iv, 
and boosted with 0.2 ml Klett-100 EEA ip, 3 days prior 
to bleeding.
^ Immunized with 0.2 ml of a 10“  ̂ dilution of a Klett-100 
suspension of heat killed jS* typhimurium ip, 14 days 
previously, and boosted with 6.2 ml Kleît-100 killed iv, 
7 days prior to bleeding.
^ Bacterial agglutination titer is the reciprocal of the 
highest dilution of serum that shows positive aggluti­
nation in duplicate tubes.
challenge, the numbers of viable Salmonella organisms 
remaining in the peritoneal fluid and cells of the con­
trol and experimental mice were determined. At least 
five mice from each group were assayed for the presence 
of Salmonella organisms. The results in Table IX show 
that the injections of EEA into the peritoneal cavities 
of LVS-immunized mice did not increase significantly 
(P .05) the rates at which viable Salmonella organisms 
were cleared from the peritoneal fluid. A significant
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Table IX, Peritoneal clearance of typhimurium fol­
lowing an ip injection of 3,5 x 10^ Salmon- 
ella organisms into normal and LV S-immuni zed 
mice, which were injected with EEA 24 hours 
previously.
Treatment
Total Number (x 
Recovered from
10*^
(mean
).of S, tvnhlmurium 
- standard error)
1° LVS^ 2° EEA^ P.E. Fluid P.E. Cells
- - 16K-15) 57(-12)
- + 120C-8) 56(^5)
+ - 120(-8) 40(±4)
+ + 112(-15) 15(±2)
^ Immunized iv with 1,7 x 10^ CFU LVS, 14 days previously
^ Injected ip with 0,2 ml Klett-100 EEA, 24 hours pre­
viously,
<P<,01) reduction was, however, observed in the number 
of viable bacteria found associated with the peritoneal 
cell fractions collected from mice in Group VI. However, 
since the peritoneal cells recovered from the control 
and experimental mice were not counted, it cannot be 
accurately determined whether the reduction in the num­
ber of bacteria was due to a decrease in the number of 
viable cell-associated Salmonella, or to a decrease in 
the total number of peritoneal cells recovered.
Regulation of delayed hypersensitivity in immune mice
A temporary depression of delayed hypersensitivity
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(DH) occurs in sensitized animals following a single in­
jection of a large quantity of specific antigen (28, 63, 
76). This loss of peripheral DH is thought to be due to 
the temporary depletion ot the temporary unreactivity of 
effector lymphocytes, as the result of their participa­
tion in an intense DH reaction that occurs at the site 
of the injected antigen.
1. Effect of an ip injection of EEA on DH in mice 
immunized 14 days previously with viable LVS.
3Mice immunized 14 days previously with 2 x 10 
viable LVS organisms were injected ip with 0.2 ml of a 
Klett-100 suspension of EEA. At intervals following the 
injection of antigen, groups of 10 mice each were tested 
for DH to EEA by the footpad method. Figure I shows 
that a significant (P<’.01) depression of delayed hyper­
sensitivity occurred in the immune mice following the 
introduction of specific antigen into the peritoneal 
cavity. Five days after the injection of EEA, the DH 
returned to near normal levels.
2. Effect of Schu challenge on DH to EEA
Mice inoculated with 1.5 x 10^ viable LVS organisms 
14 days previously were challenged ip with 6 x 10^ viable 
Schu. At 2, 24, 48, 72, and 158 hours post-challenge, 
groups of 8 mice each were tested for delayed hypersen­
sitivity to EEA. All mice were again tested for DH
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'3^
21 days after the Schu challenge. Figure II shows that 
there was a definite depression of the 24-hour footpad 
response in the immune mice as early as 2 hours after 
the Schu challenge. The DH response to EEA was sup­
pressed for at least 158 hours. When tested 21 days 
after the injection of Schu organisms, however, all sur­
viving mice elicited strong DH reactions.
The effects of an ip injection of EEA on the peritoneal 
cells from mice previously immunized with LVS.
Macrophages taken from mice infected with BCG or 
Listeria monocytogenes have been shown to be morpho­
logically distinct from macrophages collected from nor­
mal mice (8). ^  vitro. they spread on glass more rapidly
than normal macrophages and have an increased number of 
cytoplasmic granules. Mackaness (38) and others (60) 
suggested that these activated macrophages also have en­
hanced microbicidal capabilities and are largely respon­
sible for the expression of specific as well as non­
specific immunity to many of the facultative intracellular 
parasites.
A series of experiments was performed to determine 
the effect of an intraperitoneal injection of ether ex­
tracted antigen (EEA) on the peritoneal macrophages of 
LVS immunized mice.
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1" Peritoneal macrophage activation in mice immunized 
with F . tularensis strain LVS
2Normal mice and mice inoculated with 9.5 x 10 
viable LVS organisms 14 days previously were given an 
ip injection of 0.2 ml of a Klett-100 suspension of EEA.
At 6, 24, 48, 96, and 144 hours after the injection of 
specific antigen, the individual peritoneal exudates 
collected from groups of the experimental and control 
mice were assayed for the presence of activated macro­
phages. Total and differential cell counts were made of 
all peritoneal exudates in order to evaluate the effect 
of EEA on the peritoneal cell populations. Table X 
shows that injection of EEA into mice previously infected 
with LVS resulted in an increase in the percentage of ac­
tivated macrophages in the peritoneal cavity. (Figure III). 
The activation phenomenon was not, however, demonstrable 
until 48 hours after the injection of specific antigen 
and lasted only 4 days. The PEC*s harvested from normal 
recipients of EEA did not contain a similar increased 
percentage of activated macrophages,(Figure IV). In 
addition to the macrophage activation, the injection of 
EEA also caused a significant reduction in the total num­
bers of PEC*s that could be collected from the LVS-immun­
ized mice (See Table XI). The results in Table XII in­
dicate that the decrease in the total number of cells was 
due to a reduction in the numbers of lymphocytes and
Figure III.
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Peritoneal macrophages from a LVS-immunized 
.mouse injected 48 hours earlier with EEA. 
After 15 min. incubation ijn vitro. Phase 
contrast x 400.
»
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Figure IV. Peritoneal macrophages from a normal mouse 
injected ip 48 hours earlier with EEA. 
After 15 min. incubation jji vitro.
Phase contrast x 400.
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Table X. Peritoneal macrophage activation in normal
mice and in LVS-immunized mice at times
after an ip injection of EEA.
Time after injection 
of EEA^
%  Macrophage Activation 
mean (- standard error)
Normal mice LVS-immunized mice^
Uninjected 21(±3) 19(i3)
6 hours 19C-2) 33(i7)
24 hours 25(is) 31(i5)
48 hours 19(±6) 93(-2)
96 hours 22(is) 67(ie)
144 hours 16(±3) 34(Î4)
Injected ip with 0.2 ml of a Klett-100 suspension of 
EEA.
^ Immunized iv with 9.5 x 10^ CFU LVS, 14 days pre- 
vously.
macrophages that could be recovered. This decrease in 
the number of peritoneal cells, especially macrophages, 
following the injection of specific antigen is sugges­
tive of the "macrophage disappearance phenomenon" re­
ported by Nelson (45) and by Nelson and Boyden (46).
2. Peritoneal macrophage activation in mice immunized 
with LVS following an iv, sc, or ip injection of EEA
An experiment was performed to determine if intra­
venous or subcutaneous injections of specific antigen
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Table XI Total peritoneal exudate cell (PEC) popula­
tions of normal mice and LVS-immunized mice
at times after an ip injection of EEA.
Time after 
in jection
.-4Total Peritoneal Exudate Cells (x 10 )
(mean - standard error)
Normal mice LVS-immunized mice
Unin jected 3027(i215) 3039(±205)
6 hours 2343(-50) 1S21(±165)
24 hours 4425(i490) 1182(±170)
48 hours 3429(±362) not done
96 hours 4017 (±504) 4448(±438)
144 hours 3435(±269) 3498(±343)
Injected with 0.2 ml Klett-100 EEA ip.
Immunized with 950 CFU LVS iv, 14 days previously. 
Results eliminated due to clumping of cells.
would activate the peritoneal macrophages in mice pre­
viously immunized with LVS. Groups of normal mice and 
mice inoculated iv 14 days previously with 950 viable 
LVS organisms were given iv, sc, or ip injections of 
0.2 ml of a Klett-100 suspension of EEA. Forty-eight 
hours later, the peritoneal exudates from all mice were 
assayed for activated macrophages. Table XIII shows 
that EEA must be injected directly into the peritoneal 
cavity to evoke the activated macrophage response. When
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Table XII. Peritoneal exudate cell populations of
normal mice and LVS-immunized mice at
times after an ip injection of EEA.
Groups of mice, 
and time 
after injection
Total Peritoneal Exudate Cells 
10“ (mean - standard error)
Polymorphs Lymphs Macrophages
Normal
Uninjected 883(il20) 1695(ll52) 500(162)
6 hours 798(±49) 1044(ll06) 471(136)
24 hours 1409(Î232) 2243(1245) 779(1X44)
48 hours 723(-161) 1778(ll56) 962(1X42)
96 hours 1039(i308) 2183(1X96) 837(1X26)
144 hours 620(150) 2073(1323) 833(1X68)
LVS-immunized^
Unin jected 784(176) 1840(1X64) 568(176)
6 hours 647(lll4) 733(1X78) X0X(l22)
24 hours 564(ll91) 597(188) 34(l9)
48 hours c c c
96 hours 859(ll77) 2837(1X86) 1360(1X55)
144 hours 447(198) 1757(173) 892(168)
^ Injected with 0.2 ml Klett-100 EEA ip.
^ Immunized with 950 CFU LVS iv, 14 days previously.
^ Could not be determined due to clumping of the cells.
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Table XIII. Peritoneal macrophage activation in normal
mice, and in LVS-immunized mice, 48 hours
after an ip, iv, or sc injection of EEA.
% Macrçphage Activation 
mean (- standard error)
Antigen (Route) Normal Mice LVS-immunized mice®
Uninjected 14(+3) 15{+3)
EEA^ (ip) 13(+2) 89(+2)
EEA^ (iv) 20(+3) l K+2)
EEA^ (sc) 12(+4) 16(+4)
^ Immunized with 950 CFU LVS iv 14 days previously.
^ Injected with 0.2 ml Klett-100 EEA ip.
^ Injected with 0.2 ml Klett-100 EEA iv.
^ Injected with 0.2 ml Klett-100 EEA sc.
the specific cellular antigen was given by alternate 
routes of injection, only normal percentages of activated 
peritoneal macrophages were found.
3. Peritoneal macrophage activation in mice immunized 
with EEA following an ip injection of EEA
The possibility that the peritoneal macrophage ac­
tivation response in LVS-immunized mice to injected EEA 
was mediated by a specific antigen-antibody reaction 
was investigated. Previous experiments have shown that 
primary immunization with EEA induced levels of circu­
lating antibody comparable to those resulting from primary
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LVS inoculation. Groups of mice were immunized with
31.7 X 10 viable LVS organisms or with 0.2 ml of a 
Klett—100 suspension of EEA. Fourteen days later one- 
half of the mice in the immunized and control groups 
were injected ip with 0.2 ml of a Klett-100 suspension 
of EEA. All mice were checked for activated macro­
phages 42 hours later. Activated macrophages could be 
only evoked in mice that had received primary inocula­
tion with live vaccine and not in mice immunized earlier 
with EEA (Table XIV).
4. Peritoneal macrophage activation response in LVS- 
immunized mice, following ip injections of homo­
logous and heterologous antigens
The specificity of the macrophage activation reac­
tion was investigated by giving normal mice, and mice 
previously infected with the live vaccine (LVS), intra- 
peri toneal injections of homologous and heterologous 
antigens. Viable £. tularensis strain Schu cells, viable 
LVS cells, EEA, and crude ribosomes prepared from LVS 
organisms were used as homologous antigens. Francisella 
novicida cell walls, £. novicida protoplasm, BCG cell 
walls, and purified protein derivative (PPD) prepared 
from MyCobacterium tuberculosis were given as the heter­
ologous antigens. The results in Table XV show that 
high degrees of macrophage activation occurred in LVS- 
immunized mice following a single secondary injection
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Table XIV. Peritoneal macrophage activation in normal, 
EEA-immunized, and LVS-immunized mice, 42 
hours after an ip injection of EEA, deter­
mined by in vitro spreading on glass.
Group 1°LVS
Treatment 
® l°EEA^ 2°EEA^
% Macrophage Activation 
Mean (- standard error)
I - - - 14.2(Î2.7)
II - - + 18.2(il.4)
III - 25.8(i3.4)
IV - + + 19.6(ii.7)
V •I* - - 20.0(Î2.4)
VI + - + 89.0(il.6)
a Immunized with 1,700 CFU LVS iv, 14 days previously.
^ Immunized with 0.2 ml Klett-100 EEA iv, 14 days pre­
viously
^ Boosted with 0.2 ml Klett-100 EEA ip.
^ Percentage of macrophages showing spreading on glass 
after 30 minutes at 37 C,
with any of the homologous antigens. The activated macro* 
phage response was clearly a specific immunological re­
action, since similar percentages of activated macro­
phages were not recovered from the normal control mice.
Intraperitoneal injections of novicida  ̂cell walls,
£.• novicida protoplasm, or BCG cell walls also evoked 
above normal levels of activated macrophages; however.
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the response to these antigens appeared to be entirely 
nonimmunological since similar levels of activated mac­
rophages Were recovered from the normal as well as the 
LVS-immunized mice*
Table XV. Peritoneal macrophage activation determined 
by ÎJ2 vitro spreading on glass in normal 
mice and in LVS-immunized mice, 48 hours 
after an ip injection of homologous and
heterologous antigens.
%  Macrophage Activation 
Mean (- standard error)
Antigens injected 
(ip)
Normal Mice LVS--Immunized Mice
Uninjected 20(±4) 22(Î4)
LVS (10® CFU) b 90(il)
Schu (10^ CFU) b 84(is)
EEA (0.2 ml Klett-100) 24(±4) 87(Î4)
LVS crude ribosomes 
(150 ugs)
24(±2) 8 8 (-4)
F. novicida cell walls 
(300 ugs, dry wt.)
62(Î5) 55(i5 )
F. novicida protoplasm 
(300 ugs, dry wt.)
55(±6) 53(is)
BCG cell walls
(300 ugs, dry wt.)
75(±4) 72(is)
PPD (35 ugs) 23(±4) 17(il )
Immunized with 950 CFU LVS iv, 14 days previously*
Very few cells were recovered from the peritoneal 
cavity.
CHAPTER IV 
DISCUSSION
Vaccines consisting of living organisms have been 
shown to be superior to those consisting of killed cells 
for the prevention of tularemia (16, 38, 44). Although 
dead preparations of F̂ . tularensis have been used to pro­
tect mice against moderately virulent tularemia bacilli 
(35), only immunization with viable attenuated organisms 
can successfully protect mice against the fully virulent 
strains of F. tularensis. The efficacy of the viable 
organisms has been associated with a population of mac­
rophages which resist the necrotizing effects of viru­
lent tularemia bacilli (71, 72) and with the induction 
of delayed hypersensitivity to cellular antigens (16). 
Specific antibody appears to be of secondary importance 
in immunity to murine tularemia, since even large amounts 
of serum, passively transferred from resistant LVS-im­
munized mice, has failed to protect normal mice against 
infection with highly virulent F̂ . tularensis strain Schu 
organisms (10). In addition, immunization with killed 
vaccines often produced high levels of specific anti­
body without a corresponding increase in resistance (1 0 ). 
Claflin (9), suggested that the inability of the ether
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extracted antigen (EEA) of Larson (32) to protect mice 
against tularemia was not due to the destruction of 
protective antigens during its preparation, but resulted 
from a difference in the initial capture and processing 
of antigens by the cells of the reticuloendothelial 
system. Data presented in this thesis reconfirm the 
requirement of the live vaccine for protection of mice 
against infection with virulent Schu and again demon­
strate an association of delayed hypersensitivity with 
resistance.
The involvement of macrophages in the immune re­
sponse to an infection with F̂ . tularensis strain Schu 
organisms was demonstrated in this study in two ways. 
First, immunity in mice previously vaccinated with LVS 
was completely suppressed by a single injection of silica, 
an agent cytoxic for macrophages. When deprived of a 
viable macrophage population the formerly immune mice 
succumbed to infection with as few as thirty F. tular­
ensis strain Schu organisms. Second, cytological 
changes occurred in the peritoneal macrophages of 
immunized mice following an intraperi toneal challenge 
with virulent ]P. tularensis strain Schu organisms. These 
changes were characteristic of the morphological fea­
tures of "activated macrophages" which are thought to 
be the effector cells responsible for immunity to the
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faculatative intracellular parasites (40, 61). The 
above data is in good agreement with the findings of 
Nutter and Myrvik (51) and Thorpe and Marcus (71, 72), 
who demonstrated that macrophages taken from rabbits 
immune to tularemia suppressed the intracellular growth 
of tularemia bacilli jjn vitro.
Immunity to tularemia is thought to involve at 
least one, possibly two, other populations of cells in 
addition to macrophages. Claflin (10) demonstrated the 
requirement of thymus-derived lymphoid cells by supres- 
sing immunity in LVS-immunized mice with rabbit anti­
mouse thymocyte serum ̂ T S ). Recently, Luoma (35) showed 
the participation of lymphocytes of bone marrow origin 
(B-cells) by potentiating an infection of £. tularensis 
in immune mice with cyclophosphomide, a B-cell immuno­
suppressant (75). Together, these studies offer an ex­
planation for the specific nature of acquired immunity 
to tularemia. Upon specific antigenic stimulation, 
specific committed T-cells may secrete substances that 
enhance the functional capacities of macrophages, the 
ultimate effector cells. The production of specific 
serum opsonins, possibly cytophilic antibody by B-cells 
following antigenic stimulation, may also be an important 
aspect of specific resistance to tularemia, and cannot 
be entirely ruled out.
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Acquired cellular immunity to the facultative in­
tracellular parasites involves an immune mechanism that 
is not specifically directed against the organism that 
induced it* Mackaness (40) suggested that the duration 
and degree of this nonspecific resistance depends upon 
the persistence of microbial antigen within host tissues* 
He separated the course of a Listeria infection into a 
period of rapid bacterial multiplication, a period of 
bacterial inactivation, and a period of latency* Non­
specific resistance to Brucella in Listeria-infected mice 
could be demonstrated only during the period of bacterial 
inactivation * Reinfection with viable Listeria during 
the latent phase, however, recalled resistance to the 
Brucella, Likewise, nonspecific immunity to Listeria 
declined in BCG-vaccinated mice after 14 weeks but was 
recalled by a second injection of BCG (41)*
From the data presented in this thesis, it is ap­
parent that resistance to highly virulent tularensis 
induced by vaccination with attenuated tularemia organ­
isms (LVS) involves a component that can be directed 
against unrelated Salmonella typhimurium* Previously, 
Claflin and Larson (10) reported that immunization with 
the live vaccine of ^* tularensis (LVS) conferred little 
or no protection against a nonspecific challenge. Those 
investigators, however, did not attempt to restimulate
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mice immunized previously with LVS with specific antigen 
(EEA) prior to challenge. As shown here, mice infected 
with viable LVS organisms became highly refractory to 
an intraperitoneal challenge of virulent Salmonella typhi­
murium 24 hours after receiving a secondary injection of 
EEA. The lack of demonstrable nonspecific resistance in 
mice receiving only the primary injection with the viable 
LVS organisms can be attributed to the absence of con­
tinued antigenic stimulation following immunization. The 
relatively few (10^) viable LVS organisms, contained in 
the primary vaccine, were undoubtedly inactivated rapidly 
within the spleen and liver of the infected mouse. Eigels- 
bach et a_l. (17) reported that infections with LVS oc­
curred without granuloma formation and were readily 
resolved. Investigators who have used viable vaccines 
of Listeria (7), or Mycobacteria (8 , 67) to induce non­
specific resistance employed much greater numbers (1 0^ -
g
10 ) of organisms in their vaccines to insure extensive 
multiplication of the infecting organism within host 
tissues. For these more chronic infections, specific 
induction and elicitation of the nonspecific immune mech­
anism proceeds concurrently, so resistance to heterolo­
gous organisms can be demonstrated. The short-lived 
nature of the nonspecific resistance elicited by an in­
jection of EEA into a LVS-immunized mouse probably is
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due to the rapid clearance of the specific antigen (EEA), 
which prevents continued antigenic stimulation.
The effector cells responsible for the resistance to 
Salmonella are most likely activated macrophages. Sev­
eral lines of evidence support this hypothesis. First, 
the emergence of resistance to Salmonella following the 
injection of specific antigen correlated with the appear­
ance of activated macrophages in the peritoneal cavities 
of resistant mice. Second, both nonspecific resistance 
and macrophage activation occurred only in mice immun­
ized with LVS and given the eliciting injection of EEA 
ip. Neither immunological phenomenon were observed when 
LVS-immunized mice were given EEA by intravenous or sub­
cutaneous injection. Third, resistance to Ŝ , typhimurium 
and activated peritoneal macrophages could be evoked only 
in mice immunized with viable LVS organisms. Killed 
organisms (EEA) were ineffective for the primary induc­
tion of immunological changes that can result in activated 
macrophages or nonspecific resistance. An immune mecha­
nism of nonspecific resistance which involves activated 
macrophages is consistent with the findings of Blanden 
et al. (7). They found that the macrophages of the peri­
toneal cavity of mice infected 14 days previously with 
BCG were normal in respect to their ability to inacti­
vate _S. typhimurium. and were not morphologically dis-
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tinct from macrophages of normal mice. Two days after 
reinfection with BCG, however, the macrophages from the 
BCG—vaccinated mice contained increased numbers of mito­
chondria and lysosomes and were found to spread more 
rapidly on glass when cultured iji vitro. These changes 
in the macrophages were accompanied by increased resis­
tance 3J2 vivo to Salmonel la.
The activation of peritoneal macrophages in mice 
previously infected with viable tularensis is a speci­
fic immunological event. Although certain antigenic 
preparations (ie. BCG cell walls) can induce high per­
centages of activated macrophages in either normal or 
LVS-vaccinated mice, tularemia antigens elicit activated 
macrophages only in mice previously infected with viable 
LVS organisms. In addition, the elicitation of activated 
macrophages with an ip injection of EEA was not due to 
the presence of endotoxin, since no endotoxin-like mater­
ial has been isolated . from IE. tularensis cells ( 54 , 55 ). 
These data again suggest the involvement of specific 
antigen-reactive lymphoid cells for the induction and 
elicitation of nonspecific resistance.
The participation of cross-reacting antibodies in 
the mechanism of nonspecific resistance appears to be 
doubtful because serum from mice immunized with viable 
_F. tularensis strain LVS organisms failed to agglutinate
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Salmonella cells iji vitro. Although the cell bound 
anti-Salmonella antibody reported by Rowley e^ al. (58) 
to be important in resistance in mice to salmonellosis 
could go undetected by the bacterial agglutination tech­
nique, this investigator would expect that the production 
of a cytophilic antibody by B-cells would be accompanied 
by the production of detectable serum antibodies. In 
addition, a mechanism of nonspecific resistance which 
involves specific anti-tularemia antibody and the forma­
tion of antigen-antibody complexes can be discounted, 
since mice immunized with EEA did not develop enhanced 
resistance to Salmonella following an injection of speci­
fic antigen (EEA). Mice immunized with EEA or LVS were 
shown previously to produce similar levels of specific 
antibody.
Increased phagocytic function does not appear to be 
responsible for the increase in nonspecific resistance 
elicited in LVS-immunized mice with specific antigen (EEA). 
Mice made resistant to Salmonella by primary immunization 
with viable LVS organisms followed by a secondary injec­
tion of EEA did not eliminate viable Salmonella cells 
from the peritoneal cavity at a rate significantly (P .05) 
greater than that observed in normal mice. These data 
support the contention that the efficacy with which 
macrophages ingest bacteria is dependent upon the level
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of specific serum antibody and that subsequent intra­
cellular bactericidal events depend upon intrinsic 
changes in the macrophages. Peritoneal macrophages 
from specifically sensitized guinea pigs have increased 
microbicidal capabilities although there is no increase 
in the rate of phagocytosis (61). By contrast, vac­
cination with viable BCG, a potent inducer of nonspeci­
fic- immunity has been shown to enhance the phagocytic 
capacity of the RES (8 , 25).
The immune response that forms the basis of the 
nonspecific resistance observed in the foregoing experi­
ments appears to be associated with the state of delayed 
hypersensitivity. Mice previously infected with viable 
LVS showed a marked depression of delayed reactivity 
for a time following the intraperitoneal injection of 
EEA and this depression coincided with the period of 
increased resistance to Salmonella. This temporal re­
lationship between the emergence of nonspecific resis­
tance and the phenomenon of "desensitization" suggests 
that a common mechanism is involved. Delayed hyper­
sensitivity requires the participation of specifically 
committed lymphocytes and macrophages. The injection of 
specific antigen (EEA) into a sensitized host elicits 
a delayed-type reaction which involved both cell popu­
lations. The loss of delayed hypersensitivity which
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results from the injection of a large amount of EEA 
could be due either to a sequestration of macrophages 
at the injection site, or to the unreactivity of the 
specific lymphoid cells. Since other investigators (15, 
28, 75) have found similar antigen-induced depressions 
of the delayed response to be antigen-specific, the 
latter possibility seems the most plausable. In addi­
tion, Schlossman e^ al. (63) found that blood or peri­
toneal lymphocytes from a "desensitized" animal did not 
respond to specific antigenic stimulation by either DNA 
synthesis or production of MIF. The exhaustion of avail­
able soluble mediators in the antigen-reactive lymphocytes 
could explain this temporary unresponsiveness. Salvin 
et al> (62) have shown that MIF can be found in the cir­
culation of mice infected with BCG following an intra­
venous injection of old tuberculin (OT) or living BCG. 
Lymphokines released in this manner could exert their 
biological activities on macrophages. A similar depres­
sion of the delayed footpad response occurred in LVS- 
immunized mice challenged with a large number of viable 
F̂ . tularensis strain Schu organisms. These results indi­
cate that the immune response to an active infection also 
involves the cells that participate in delayed hyper­
sensitivity. Again, however, the precise relationship 
between the two immunological events remains unanswered.
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From the evidence presented here, it cannot be deter­
mined 'which of the following three possible mechanisms 
are responsible for the above observations: (1) both DH 
and CMI are-mediated by a single soluble mediator (ie.
MIF)  ̂ which is released from a homogeneous population 
of lymphocytes following specific antigenic stimulation, 
(2) separate mediators for DH and CMI are released by 
a single homogeneous population of antigen-reactive 
lymphocytes, and (3) separate mediators for DH and CMI 
are released by a heterogenous population of antigen- 
reactive lymphocytes.
The intraperitoneal injection of specific antigen 
(EEA) into mice previously immunized with LVS is fol­
lowed by a marked decrease in the number of cells that 
can be recovered from the peritoneal cavity. The most 
profound decrease occurs 24 hours after the injection of 
EEA and results from the substantial loss of macrophages 
(92%) and lymphocytes from the peritoneal fluid. These 
findings are in good agreement with those reported by 
Nelson (48). He demonstrated the almost complete dis­
appearance of macrophages from the fluid phases of the 
peritoneal exudates collected from BCG vaccinated guinea 
pigs following the injection of tuberculin (PPD). This 
"macrophage disappearance reaction", or MDR, has also 
been demonstrated to occur in hypersensitive mice follow­
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ing the injection of specific antigen (45), or in normal 
mice following the injection of bacterial endotoxin (81). 
The MDR has been transferred from hypersensitive animals 
to normal recipients with lymphocytes (45) and is thought 
to be a manifestation of delayed hypersensitivity (44). 
Nelson and North (47) demonstrated that the peritoneal 
cells do not actually migrate from the peritoneal cavity 
but form cel 1-aggregates which adhere to the peritoneal 
lining. It was suggested that the clumping of the mac­
rophages resulted from an antigen-induced increase in 
their adhesiveness for each other and for the lining of 
the peritoneal cavity. Entrapment of other cells in the 
clumps of "sticky'* macrophages could account for the 
apparent disappearance of peritoneal lymphocytes ob­
served in this study. The temporal relationship between 
the MDR and the increase in resistance to mouse virulent 
_S. typhimurium again suggests a common mechanism for both 
the delayed hypersensitivity reaction and nonspecific 
resistance.
In summary, specific resistance to tularemia, in­
duced by immunization with viable vaccine organisms, re­
quires the participation of macrophages as effector cells. 
Upon specific antigenic stimulation, the macrophages in 
immune mice showed morphological characteristics of 
activated macrophages. The appearance of activated
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macrophages in the peritoneal cavity of immune mice 
corresponded with the emergence of resistance to ty­
phimurium in vivo. and was associated with two mani­
festations of delayed hypersensitivity; there was a 
temporary loss of delayed hypersensitivity, and there 
was a temporary "disappearance” of macrophages from the 
peritoneal cavity.
CHAPTER V
SUMMARY
Mice were immunized with the live vaccine of Fran- 
cisella tularensis or with ether extracted antigens (EEA) 
of F̂ . tularensis. Although comparable levels of specific 
antibody were induced by both vaccines, only inoculation 
with viable cells provided protection against challenges 
with highly virulent tularensis strain Schu. The fol­
lowing lines of evidence indicated that this resistance 
is associated with activated macrophages. 1. Treatment 
with Min-U-Sil, an agent which is cytoxic for macrophages, 
rendered immune mice fully susceptible to challenges with 
low numbers of virulent tularemia bacilli. 2. Activated 
macrophages appeared in the peritoneal cavity of immune 
mice following an ip challenge with viable tularensis 
strain Schu organisms. 3. Ether extracted antigen (EEA) 
provoked a response in tularemia-immune mice that was 
protective against challenges with unrelated Sm typhi­
murium. The development and duration of this response 
corresponded with the presence of activated macrophages 
in the peritoneal cavity.
Resistance in mice to F̂ . tularensis strain Schu 
following immunization with viable vaccine organisms
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was accompanied by the acquisition of delayed hyper­
sensitivity to EEA. In addition, the elicitation of 
nonspecific resistance to typhimurium with a single 
injection of EEA into mice immunized with LVS was asso­
ciated with three manifestations of delayed hypersen­
sitivity: a temporary depression of the delayed cutan­
eous response to EEA, the apparent loss of macrophages 
from the peritoneal cavity, and a subsequent.increase 
in the percentage of activated peritoneal macrophages. 
Together, these data indicated that a single cellular 
mechanism may have provided the basis for both delayed 
hypersensitivity to cellular antigens and immunity to 
infection with homologous or heterologous challenge 
organisms.
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